Carmel Verrier | Biological Therapy/Immunotherapy Chemotherapy Gene Therapy Pain Management Photodynamic Therapy Targeted Therapy

Insurance Accepted

Aetna Cigna First Health PPO Humana Medicaid Medicare MultiPlan

Saint Louis University

Medical School

New York Medical College

Residency

Duke University Hospital

Fellowship

AR State Medical License: 2008 - 2017

TN State Medical License: 2007 - 2018

MS State Medical License: 2007 - 2017

American Board of Internal Medicine: Medical Oncology

American Board of Internal Medicine - Oncology

Baptist Memorial Hospital-Memphis

Languages: English/Spanish

(901) 226-5000

6019 Walnut Grove Rd

Memphis, Tennessee 38120

Yeast screens identify the RNA polymerase II CTD and SPT5 as relevant targets of BRCA1 interaction.

Bennett, C.B., Westmoreland, T.J., Verrier, C.S., Blanchette, C.B., Sabin, T.L., Phatnani, H.P., Mishina, Y.V., Huper, G., Selim, A.L., Madison, E.R., Bailey, D.D., Fa...; PLoS One. 2008.

Bio & Insurance Information

Insurance Accepted

Aetna Cigna First Health PPO Humana Medicaid Medicare MultiPlan
Education & Training

Saint Louis University
Medical School
New York Medical College
Residency
Duke University Hospital
Fellowship
Board Certifications

American Board of Internal Medicine - Oncology
Hospital & Practice

Baptist Memorial Hospital-Memphis

Languages: English/Spanish

(901) 226-5000

6019 Walnut Grove Rd

Memphis, Tennessee 38120
Read More
Publications & Memberships

Dr. Carmel Verrier has contributed to 1 publications.

Yeast screens identify the RNA polymerase II CTD and SPT5 as relevant targets of BRCA1 interaction.

Bennett, C.B., Westmoreland, T.J., Verrier, C.S., Blanchette, C.B., Sabin, T.L., Phatnani, H.P., Mishina, Y.V., Huper, G., Selim, A.L., Madison, E.R., Bailey, D.D., Fa...; PLoS One. 2008.
See more >>

Request a call back

Request a call back

Insurance Accepted

Dr. Carmel Verrier has contributed to 1 publications.

Insurance Accepted

Dr. Carmel Verrier has contributed to 1 publications.